• Register
  • Login
    • en
    • ru
    • uz
  • en
  • ru
  • uz
Register Login
  • Current
  • Archives
    • About the Journal
    • Submissions
    • Editorial Masthead
    • Privacy Statement
    • Contact
Current Archives
About the Journal Submissions Editorial Masthead Privacy Statement Contact
  1. Home
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

Found one item.
  • OPTIMIZATION OF COMPREHENSIVE TREATMENT OF LICHEN RUBER PLANUS: CLINICAL-IMMUNOLOGICAL STUDY

    Tashkenbaeva U.A., Safarov Kh.Kh.

    Objective: to study the clinical and immunological characteristics of various forms of LC and to evaluate the effectiveness of combined therapy using narrow-band UVB therapy (311 nm), excimer laser (308 nm), and topical tacrolimus. Materials and methods: The prospective study included 118 patients with verified CPL, randomized into 4 groups. The 1st group (n=28) received standard therapy (topic corticosteroids, antihistamines, vitamins), the 2nd group (n=29) received standard therapy + UVB-311, the 3rd group (n=30) received standard therapy + UVB-311 + excimer laser, the 4th group (n=31) received standard therapy + UVB-311 + excimer laser + tacropic cream. The effectiveness was assessed by the dynamics of LPASI, REU, VAS indices, cytokine levels (IL-6, IL-1β, IL-10), dermatoscopic picture, and quality of life (HADS). Results: The highest clinical effectiveness was noted in the 4th group: a decrease in the LPASI index by 85.1% (p<0.001), the REU index by 0.64±0.23 (p<0.01), and the intensity of itching by VAS by 82%. In this same group, normalization of the cytokine profile (IL-6, IL-1β, IL-10) and maximum improvement of the quality of life (reduction of anxiety and depression according to HADS by 77.2% and 87.8%, respectively) were recorded. Dermatoscopic signs of activity (Wickham's network, vascular patterns) regressed most significantly in the combined therapy groups. Conclusions: Combined CPL therapy, including UVB-311, 308 nm excimer laser, and topical tacrolimus, is a highly effective pathogenetically justified approach that provides not only clinical improvement but also normalization of immunological indicators and improvement of patients' quality of life.

    22-26
    09-01-2026
    Read more
1 - 1 of 1 items

Information

  • For Readers
  • For Authors
  • For Librarians

Latest publications

  • Atom logo
  • RSS2 logo
  • RSS1 logo
TNMU Publishing

We bring together researchers, knowledge, and technology to accelerate medical progress and improve public health.

 

Navigation

Home
Journals
Conferences
To Authors
To Reviewers
Publishing services

Support

Guidelines for authors
Publication ethics
About us
FAQ
Feedback

Contacts

 
Uzbekistan, Tashkent,
Almazar District, Shifokorlar, 21
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
Login
Central Asian Journal of Medicine
Login
* Required
* Required
Forgot your password?
Keep me logged in
Register